Test Price
2,800 AED✅ Home Collection Available
SARS-CoV-2 Respiratory Comprehensive Panel in UAE | 2,800 AED | DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
DNA Labs UAE offers the SARS-CoV-2 Respiratory Comprehensive Panel, a dual-methodology assay combining real-time RT-PCR with whole genome sequencing (WGS) for definitive detection and variant lineage identification from a single nasopharyngeal swab. This test delivers 99.9% diagnostic sensitivity with full variant profiling, exceeding standard RT-PCR capabilities.
- ✓ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 15189 accredited processing with dual-method confirmation.
- ✓ Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation and next steps.
- ✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This comprehensive panel detects SARS-CoV-2 RNA with simultaneous whole genome sequencing for complete variant identification from a single nasopharyngeal swab. Results are actionable within 24 to 48 hours, providing both qualitative detection and detailed lineage assignment (Pango lineage, Nextclade). The dual-methodology workflow ensures no variant goes undetected, even novel lineages with spike protein mutations.
| Feature | Our Test (SARS-CoV-2 Respiratory Comprehensive Panel) | Closest Alternative (Standard RT-PCR) |
|---|---|---|
| Methodology | Whole Genome Sequencing (WGS) + Real-Time RT-PCR (qPCR) | Real-Time RT-PCR only |
| Diagnostic Sensitivity | 99.9% (including all variants) | ~95% (may miss novel variants) |
| Turnaround Time | 24–48 hours | 24–48 hours |
| Price | 2,800 AED | ~1,500 AED (may vary) |
| Variant Lineage Report | Yes (Pango lineage, Nextclade) | No |
| DHA Guideline Alignment | Full DHA sequencing and reporting compliance for communicable disease surveillance | Compliant only for detection reporting |
Physician Insight & Safety Protocols
Dr. Ajay Singh (DHA Registration ID: 36234132) states: "A positive SARS-CoV-2 result confirms active viral shedding, but clinical correlation with symptom onset, exposure history, and vital signs is mandatory. Patients should initiate self-isolation per DHA communicable disease protocols immediately upon receiving a positive report. This molecular test is a diagnostic adjunct and does not replace a comprehensive clinical evaluation by a licensed physician. Share your complete report with your treating doctor or contact our clinical support team for guidance on next steps."
Important Advisory for Patients
A positive result does not indicate disease severity or immunity status. Continue all prescribed therapies unless explicitly instructed otherwise by your physician. Use this report as one component of your clinical picture, not as a standalone treatment guide. If you develop worsening symptoms after collection, seek immediate medical attention.
Exclusion Criteria & Red Flags
- Exclusion: Severe respiratory distress (SpO₂ below 90% on room air); inability to tolerate nasopharyngeal swab due to nasal obstruction or recent nasal surgery within 48 hours.
- Exclusion: Active epistaxis or untreated coagulopathy; home collection contraindicated in patients with unstable vital signs or requiring emergency intervention.
- Red Flag – Seek ER: Difficulty breathing, persistent chest pain, confusion, or cyanosis (bluish lips or face) — call 998 immediately.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the SARS-CoV-2 Respiratory Comprehensive Panel?
This test achieves 99.9% diagnostic sensitivity by combining real-time RT-PCR with whole genome sequencing, ensuring reliable detection of all known and emerging SARS-CoV-2 variants, including Omicron sublineages and recombinants.
2. When will I receive my test results?
Results are delivered within 24 to 48 hours from sample collection (collections processed Monday, Wednesday, and Friday) via our secure patient portal and WhatsApp notification.
3. Do I need to fast or prepare before the swab?
No fasting is required for the nasopharyngeal swab. Please avoid using nasal sprays or decongestants for at least two hours prior to collection. No other dietary or medication adjustments are necessary.
4. What does the variant lineage report include?
The report provides the assigned Pango lineage (e.g., JN.1, KP.2), Nextclade clade designation, and spike protein mutation profile. This information supports epidemiological tracking and informs public health response under DHA surveillance programs.
5. Can I use this test for travel clearance?
Yes, the test meets UAE travel screening requirements. However, please verify entry requirements with your destination country, as some jurisdictions may require a standard RT-PCR certificate without sequencing data.
UAE Regulatory & Data Privacy Adherence
Your data is protected under UAE federal law.
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Governs the collection, processing, and storage of your personal information with strict confidentiality safeguards.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Mandates secure handling of electronic health records and telemedicine data.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Establishes the legal framework for clinical testing safety, patient consent, and professional accountability.
DNA Labs UAE operates under DHA Facility License Number 1143 and complies with all applicable UAE data protection and health information governance regulations.
Clinical & Logistical Metadata
| Test Name | SARS-CoV-2 Respiratory Comprehensive Panel (WGS + RT-PCR) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 24–48 hours from sample receipt (collections processed Monday, Wednesday, Friday) |
| Sample Type / Matrix | Nasopharyngeal swab (NP swab) in viral transport medium. VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM. |
| Methodology Used | Whole Genome Sequencing (WGS) on Illumina platform + Real-Time RT-PCR (qPCR) with dual-target amplification (ORF1ab, N gene, S gene) |
| ICD-10-CM Code | U07.1 |
| LOINC Code | 94534-5 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians